Application of chemoenzymatic hydrolysis in the synthesis of 2-monoacylglycerols
摘要:
The selective biocatalyzed synthesis of 2-monoacylglycerols (2-MAGs) through the use of commercially available immobilized Candida antarctica (Novozym435) and Rhizomucor miehei is explored. Reactions at room temperature result in the formation of a 2-MAG and a corresponding ethyl ester of the fatty acid with immobilized C. antarctica within 2 h with yields ranging from 36% to 83%. Similar reaction conditions with immobilized R. miehei yielded exclusively the 2-MAG after 24 h with yields ranging from 37% to 88%. Yields vary on the acyl group at the sn-2 position and choice of enzyme involved. (c) 2012 Elsevier Ltd. All rights reserved.
Application of chemoenzymatic hydrolysis in the synthesis of 2-monoacylglycerols
摘要:
The selective biocatalyzed synthesis of 2-monoacylglycerols (2-MAGs) through the use of commercially available immobilized Candida antarctica (Novozym435) and Rhizomucor miehei is explored. Reactions at room temperature result in the formation of a 2-MAG and a corresponding ethyl ester of the fatty acid with immobilized C. antarctica within 2 h with yields ranging from 36% to 83%. Similar reaction conditions with immobilized R. miehei yielded exclusively the 2-MAG after 24 h with yields ranging from 37% to 88%. Yields vary on the acyl group at the sn-2 position and choice of enzyme involved. (c) 2012 Elsevier Ltd. All rights reserved.
Use of a compound having the formula (1), (2), (3), or (4) or combinations thereof, for providing a source of butyrate with improved organoleptic properties wherein R
1
, R
2
, R
3
, R
4
, R
5
and R
6
are independently a long chain fatty acid having between 16 and 20 carbons.
[EN] DIETARY BUTYRATE AND ITS USES<br/>[FR] BUTYRATE ALIMENTAIRE ET SES UTILISATIONS
申请人:NESTLE SA
公开号:WO2020234354A1
公开(公告)日:2020-11-26
1. Use of a compound having the formula (1) (2) (3) or (4) or combinations thereof, for use in promotion of bone growth and/or prevention and/or treatment of bone disorders associated to bone growth impairment wherein R1, R2, R3, R4, R5 and R6 are independently a long chain fatty acid having between 16 and 20 carbons.
A nutritional composition for providing a source of butyrate or butyric acid comprising a compound having the formula (1) wherein R6 is a long chain fatty acid having between 16 and 20 carbons.